202 related articles for article (PubMed ID: 35915275)
1. Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease.
Di Tella S; Lo Monaco MR; Petracca M; Zinzi P; Solito M; Piano C; Calabresi P; Silveri MC; Bentivoglio AR
J Neurol; 2022 Dec; 269(12):6634-6640. PubMed ID: 35915275
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.
Petracca M; Di Tella S; Solito M; Zinzi P; Lo Monaco MR; Di Lazzaro G; Calabresi P; Silveri MC; Bentivoglio AR
Eur J Neurol; 2022 Jul; 29(7):1940-1951. PubMed ID: 35357736
[TBL] [Abstract][Full Text] [Related]
3. Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.
Wright GEB; Collins JA; Kay C; McDonald C; Dolzhenko E; Xia Q; Bečanović K; Drögemöller BI; Semaka A; Nguyen CM; Trost B; Richards F; Bijlsma EK; Squitieri F; Ross CJD; Scherer SW; Eberle MA; Yuen RKC; Hayden MR
Am J Hum Genet; 2019 Jun; 104(6):1116-1126. PubMed ID: 31104771
[TBL] [Abstract][Full Text] [Related]
4. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
5. Huntington's Disease: Relationship Between Phenotype and Genotype.
Sun YM; Zhang YB; Wu ZY
Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
[TBL] [Abstract][Full Text] [Related]
6. Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Paulsen JS; Long JD; Ross CA; Harrington DL; Erwin CJ; Williams JK; Westervelt HJ; Johnson HJ; Aylward EH; Zhang Y; Bockholt HJ; Barker RA;
Lancet Neurol; 2014 Dec; 13(12):1193-201. PubMed ID: 25453459
[TBL] [Abstract][Full Text] [Related]
7. What is the impact of education on Huntington's disease?
López-Sendón JL; Royuela A; Trigo P; Orth M; Lange H; Reilmann R; Keylock J; Rickards H; Piacentini S; Squitieri F; Landwehrmeyer B; Witjes-Ane MN; Jurgens CK; Roos RA; Abraira V; de Yébenes JG;
Mov Disord; 2011 Jul; 26(8):1489-95. PubMed ID: 21432905
[TBL] [Abstract][Full Text] [Related]
8. Genetics of Huntington disease.
Nance MA
Handb Clin Neurol; 2017; 144():3-14. PubMed ID: 28947123
[TBL] [Abstract][Full Text] [Related]
9. Loss of CAA interruption and intergenerational CAG instability in Chinese patients with Huntington's disease.
Bao YF; Li XY; Dong Y; Wu ZY
J Mol Med (Berl); 2023 Jul; 101(7):869-876. PubMed ID: 37231148
[TBL] [Abstract][Full Text] [Related]
10. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
[TBL] [Abstract][Full Text] [Related]
11. Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.
Unschuld PG; Joel SE; Pekar JJ; Reading SA; Oishi K; McEntee J; Shanahan M; Bakker A; Margolis RL; Bassett SS; Rosenblatt A; Mori S; van Zijl PC; Ross CA; Redgrave GW
Psychiatry Res; 2012; 203(2-3):166-74. PubMed ID: 22974690
[TBL] [Abstract][Full Text] [Related]
12. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
[TBL] [Abstract][Full Text] [Related]
13. Late-onset Huntington's disease with 40-42 CAG expansion.
Capiluppi E; Romano L; Rebora P; Nanetti L; Castaldo A; Gellera C; Mariotti C; Macerollo A; Cislaghi MG
Neurol Sci; 2020 Apr; 41(4):869-876. PubMed ID: 31820322
[TBL] [Abstract][Full Text] [Related]
14. Modeling Variability in the Progression of Huntington's Disease A Novel Modeling Approach Applied to Structural Imaging Markers from TRACK-HD.
Warner JH; Sampaio C
CPT Pharmacometrics Syst Pharmacol; 2016 Aug; 5(8):437-45. PubMed ID: 27481337
[TBL] [Abstract][Full Text] [Related]
15. Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).
Quaid KA; Eberly SW; Kayson-Rubin E; Oakes D; Shoulson I;
Clin Genet; 2017 Jun; 91(6):824-831. PubMed ID: 27740685
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and genetic study of juvenile form of Huntington's disease].
Zdzienicka E; Rakowicz M; Mierzewska H; Hoffman-Zacharska D; Jakubowska T; Poniatowska R; Sułek A; Waliniowska E; Zalewska U; Kulczycki J; Zaremba J
Neurol Neurochir Pol; 2002; 36(2):245-58. PubMed ID: 12046502
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic characteristics of late-onset Huntington's disease.
Oosterloo M; Bijlsma EK; van Kuijk SM; Minkels F; de Die-Smulders CE
Parkinsonism Relat Disord; 2019 Apr; 61():101-105. PubMed ID: 30528461
[TBL] [Abstract][Full Text] [Related]
18. The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington's Disease Patients.
Tell-Marti G; Puig-Butille JA; Gimenez-Xavier P; Segu-Roig A; Potrony M; Badenas C; Alvarez V; Millán JM; Trujillo-Tiebas MJ; Ramos-Arroyo MA; Milà M; Puig S
Mol Neurobiol; 2017 Jul; 54(5):3906-3910. PubMed ID: 27924526
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for the onset and progression of Huntington disease.
Chao TK; Hu J; Pringsheim T
Neurotoxicology; 2017 Jul; 61():79-99. PubMed ID: 28111121
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Family History on the Clinical Features of Huntington's Disease.
Kringlen G; Kinsley L; Aufox S; Rouleau G; Bega D
J Huntingtons Dis; 2017; 6(4):327-335. PubMed ID: 28984613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
